Skip to content

Complete Blood Count (CBC) Test

Published: August 9, 2026Updated: August 16, 2026

This genetic test detects large deletions or duplications in the ACVRL1 and ENG genes, which are associated with Hereditary Hemorrhagic Telangiectasia (HHT).

Quick summary

{"The test uses MLPA technology to find large genetic changes (deletions/duplications) in two specific genes","It helps diagnose Hereditary Hemorrhagic Telangiectasia (HHT), a condition causing abnormal blood vessels","A blood or tissue sample is required for testing","Results can guide treatment and family screening decisions"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
69481-0
Short code
ACVRL1/ENG MLPA
Synonyms
ACVRL1+ENG gene Del+Dup Bld/T MLPA
Category
chemistry
Sample
whole-blood
Container
EDTA tube (purple top) or ACD tube (yellow top)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
≥ 0 years
Method
MLPA (Multiplex Ligation-dependent Probe Amplification)
CPT
81403
SNOMED
429060002
Specimen volume
3-5 mL whole blood
Stability
Whole blood: room temperature 24-72 hours, refrigerated 72 hours to 7 days. Extracted DNA: refrigerated 1 week, frozen -20°C indefinitely
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
168–336 hours
Order
routine

What is a complete blood count (CBC) test and what does it measure in my blood?

This test looks for large deletions (missing pieces) or duplications (extra copies) in two genes called ACVRL1 and ENG. These genes are important for normal blood vessel development. The test uses a technique called MLPA (Multiplex Ligation-dependent Probe Amplification), which can detect these larger genetic changes that standard genetic sequencing might miss.

Why might my healthcare provider order a complete blood count (CBC) test for me?

Your doctor may recommend this test if you or your family members have symptoms of Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome. Common signs include frequent nosebleeds, red spots on the skin and mucous membranes (telangiectasias), and arteriovenous malformations (AVMs) in the lungs, brain, or liver. This test can confirm a genetic diagnosis and help identify family members who may be at risk.

How is a complete blood count (CBC) test performed, and what should I expect during the blood draw?

A healthcare professional will collect a blood sample from a vein in your arm, or in some cases, a tissue sample may be used. The sample is then sent to a specialized laboratory where MLPA technology is used to analyze the ACVRL1 and ENG genes for deletions or duplications. The procedure is simple and takes only a few minutes to collect the sample.

What do my complete blood count (CBC) results mean, and how will I receive them?

A 'positive' result means a deletion or duplication was found in the ACVRL1 or ENG gene, which supports a diagnosis of HHT. A 'negative' result means no large deletion or duplication was found, but it does not completely rule out HHT because other types of genetic changes (smaller mutations) may still be present. Your doctor will interpret the results in the context of your symptoms and family history.

Reference range

No deletion or duplication detected in ACVRL1 and ENG genes. Pathogenic variants not identified.N/A

Specimen: whole-blood

No special preparation required. Patient may eat and drink normally before specimen collection. Inform patient that this is a genetic test with implications for family members.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

This test is primarily used to confirm a diagnosis of Hereditary Hemorrhagic Telangiectasia (HHT), a genetic disorder causing abnormal blood vessel formation. Identifying the specific genetic cause helps guide clinical management, including screening for potentially serious complications like lung and brain AVMs. Family members can also be tested to determine if they carry the same genetic change, enabling early monitoring and intervention if needed.

Frequently asked questions

How long does it take to get results?
Results typically take 2-4 weeks because the analysis requires specialized laboratory processing. Your healthcare provider will contact you when results are available.
Do I need to fast before this test?
No, fasting is not required for this genetic blood test. You can eat and drink normally before the sample is collected.
Will my insurance cover this test?
Coverage varies by insurance plan. Many plans cover genetic testing when there is a clinical indication (symptoms or family history). We recommend contacting your insurance company to verify coverage before testing.
Can this test detect all types of genetic mutations?
No, this test specifically detects large deletions and duplications in the ACVRL1 and ENG genes. It does not detect small sequence changes (single nucleotide variants). Other tests may be needed to look for those types of mutations.
Should my family members also be tested?
If a pathogenic deletion or duplication is found in you, your first-degree relatives (parents, siblings, and children) may benefit from genetic counseling and testing to determine if they carry the same genetic change. This helps with early detection and management of HHT-related complications.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy